Need to bankroll efforts to roll back malaria

By  

Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Accounting for Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial

By Dallas Michael  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 4, 2008-07 ,pp. : 631-638

Taylor & Francis Ltd

Access to resources Recommend Favorite

Paediatric Postmarketing Pharmacovigilance Using Prescription-Event Monitoring: Comparison of the Adverse Event Profiles of Lamotrigine Prescribed to Children and Adults in England

By Aurich-Barrera Beate   Wilton Lynda   Brown David   Shakir Saad  

Drug Safety, Vol. 33, Iss. 9, 2010-09 ,pp. : 751-763

Adis International

Access to resources Recommend Favorite

Malaria Pharmacovigilance in Africa: Lessons from a Pilot Project in Mpumalanga Province, South Africa

By Mehta Ushma   Durrheim David   Mabuza Aaron  

Drug Safety, Vol. 30, Iss. 10, 2007-01 ,pp. : 899-910

Adis International

Access to resources Recommend Favorite

Commentary on “Accounting for the Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial”

By Liu Jen-pei  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 4, 2008-07 ,pp. : 641-643

Taylor & Francis Ltd

Access to resources Recommend Favorite